FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1969804959> ?p ?o ?g. }

• W1969804959 endingPage "255" @default.
• W1969804959 startingPage "249" @default.
• W1969804959 abstract "OBJECTIVES It has been suggested that normal women receiving oral contraceptives (OC) may develop a series of metabolic side-effects which relate to the risk of cardiovascular disease. These metabolic disturbances include changes in glucose and insulin metabolism, raised serum lipid and lipoprotein concentrations and elevated blood pressure. All these changes indicate that OC might cause insulin resistance. We have prospectively examined the effect of OC on insulin resistance and lipid metabolism including Lp(a) values. PATIENTS The study group comprised 13 normally menstruating Chinese women. DESIGN The study subjects were given a combined triphasic oral contraceptive which was administered on a 21-day on, 7-day off medication cyclic regimen, the first pill being administered on day 5 from the beginning of menses. The metabolic investigations were carried out during luteal phase before OC and again the third week of the third month of OC administration. MEASUREMENTS Metabolic evaluation including insulin secretion and insulin-mediated glucose uptake were evaluated by oral glucose tolerance test and the modification of insulin suppression test. Fasting triglyceride, cholesterol, HDL-cholesterol and Lp(a) concentrations were also measured. RESULTS The plasma glucose and insulin responses during a 75-g oral glucose challenge increased significantly (P<0 05 and P<003, respectively). The steady-state plasma glucose (SSPG) concentrations achieved during constant infusion of glucose, insulin and somatostatin increased significantly after 3 cycles of OC administration (glucose 7–5±08 vs 124±07 mmol/l, P<0001) while the steady-state plasma insulin (SSPI) concentrations were relatively similar (410±14 vs 391 ±7 pmol/l, NS). Plasma triglyceride levels increased significantly (0 81 ±012 vs 1 09±0 19 mmol/l, P<0 03) following OC administration. Fasting plasma cholesterol, HDL cholesterol and calculated LDL cholesterol concentrations did not change as compared with baseline values, nor did the ratio of total cholesterol to HDL cholesterol. The Lp(a) concentrations did not change during the administration of OC (81 ±25 vs 71 ±21 mg/l, NS). CONCLUSIONS These data indicated that intake of OC for 3 cycles induced glucose intolerance, hyperinsulinaemia and insulin resistance in normal menstruating Chinese women. These changes occurred in association with elevated plasma triglyceride concentrations and no alteration in Lp(a) or other lipid values." @default.
• W1969804959 created "2016-06-24" @default.
• W1969804959 creator A5012309616 @default.
• W1969804959 creator A5027914890 @default.
• W1969804959 creator A5031812511 @default.
• W1969804959 creator A5056317434 @default.
• W1969804959 creator A5057023395 @default.
• W1969804959 date "1994-02-01" @default.
• W1969804959 modified "2023-10-18" @default.
• W1969804959 title "Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives" @default.
• W1969804959 cites W11959 @default.
• W1969804959 cites W1625153045 @default.
• W1969804959 cites W194386581 @default.
• W1969804959 cites W1963974554 @default.
• W1969804959 cites W1964711800 @default.
• W1969804959 cites W1966376345 @default.
• W1969804959 cites W1993273712 @default.
• W1969804959 cites W1996388383 @default.
• W1969804959 cites W1999381960 @default.
• W1969804959 cites W2001709570 @default.
• W1969804959 cites W2013407151 @default.
• W1969804959 cites W2014860937 @default.
• W1969804959 cites W2034982899 @default.
• W1969804959 cites W2039313590 @default.
• W1969804959 cites W2044426380 @default.
• W1969804959 cites W2046331932 @default.
• W1969804959 cites W2049700432 @default.
• W1969804959 cites W2050023717 @default.
• W1969804959 cites W2065855706 @default.
• W1969804959 cites W2066315702 @default.
• W1969804959 cites W2067209800 @default.
• W1969804959 cites W2067803293 @default.
• W1969804959 cites W2091342496 @default.
• W1969804959 cites W2112538182 @default.
• W1969804959 cites W2116066447 @default.
• W1969804959 cites W2116404316 @default.
• W1969804959 cites W2126217622 @default.
• W1969804959 cites W2152248667 @default.
• W1969804959 cites W2159900676 @default.
• W1969804959 cites W2167162747 @default.
• W1969804959 cites W2204919075 @default.
• W1969804959 cites W2231694041 @default.
• W1969804959 cites W2251704643 @default.
• W1969804959 cites W2329533302 @default.
• W1969804959 cites W2337024630 @default.
• W1969804959 cites W2596242802 @default.
• W1969804959 cites W4239834596 @default.
• W1969804959 cites W4240249109 @default.
• W1969804959 cites W4249242648 @default.
• W1969804959 cites W4251232916 @default.
• W1969804959 doi "https://doi.org/10.1111/j.1365-2265.1994.tb02476.x" @default.
• W1969804959 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8137525" @default.
• W1969804959 hasPublicationYear "1994" @default.
• W1969804959 type Work @default.
• W1969804959 sameAs 1969804959 @default.
• W1969804959 citedByCount "18" @default.
• W1969804959 countsByYear W19698049592012 @default.
• W1969804959 countsByYear W19698049592013 @default.
• W1969804959 countsByYear W19698049592014 @default.
• W1969804959 countsByYear W19698049592016 @default.
• W1969804959 countsByYear W19698049592017 @default.
• W1969804959 countsByYear W19698049592021 @default.
• W1969804959 crossrefType "journal-article" @default.
• W1969804959 hasAuthorship W1969804959A5012309616 @default.
• W1969804959 hasAuthorship W1969804959A5027914890 @default.
• W1969804959 hasAuthorship W1969804959A5031812511 @default.
• W1969804959 hasAuthorship W1969804959A5056317434 @default.
• W1969804959 hasAuthorship W1969804959A5057023395 @default.
• W1969804959 hasConcept C126322002 @default.
• W1969804959 hasConcept C134018914 @default.
• W1969804959 hasConcept C17093226 @default.
• W1969804959 hasConcept C2777056448 @default.
• W1969804959 hasConcept C2777391703 @default.
• W1969804959 hasConcept C2778163477 @default.
• W1969804959 hasConcept C2778913445 @default.
• W1969804959 hasConcept C2779113265 @default.
• W1969804959 hasConcept C2779306644 @default.
• W1969804959 hasConcept C2780352109 @default.
• W1969804959 hasConcept C2780833929 @default.
• W1969804959 hasConcept C3017594256 @default.
• W1969804959 hasConcept C71924100 @default.
• W1969804959 hasConceptScore W1969804959C126322002 @default.
• W1969804959 hasConceptScore W1969804959C134018914 @default.
• W1969804959 hasConceptScore W1969804959C17093226 @default.
• W1969804959 hasConceptScore W1969804959C2777056448 @default.
• W1969804959 hasConceptScore W1969804959C2777391703 @default.
• W1969804959 hasConceptScore W1969804959C2778163477 @default.
• W1969804959 hasConceptScore W1969804959C2778913445 @default.
• W1969804959 hasConceptScore W1969804959C2779113265 @default.
• W1969804959 hasConceptScore W1969804959C2779306644 @default.
• W1969804959 hasConceptScore W1969804959C2780352109 @default.
• W1969804959 hasConceptScore W1969804959C2780833929 @default.
• W1969804959 hasConceptScore W1969804959C3017594256 @default.
• W1969804959 hasConceptScore W1969804959C71924100 @default.
• W1969804959 hasIssue "2" @default.
• W1969804959 hasLocation W19698049591 @default.
• W1969804959 hasLocation W19698049592 @default.
• W1969804959 hasOpenAccess W1969804959 @default.

• next